📌 Tempus – USA 🇺🇸

🔍 What is it?

Tempus is a precision medicine company that provides real-world data (RWD) from multimodal sources, including genomic sequencing, electronic health records (EHR), and imaging. It specializes in oncology and other therapeutic areas, offering rich biomarker insights, treatment response tracking, and clinical outcomes data to support drug development and personalized medicine research.

-

📊 Key Features & Scope

📍 Geographical coverage: USA 🇺🇸 (nationwide genomic and clinical data)
🏥 Data type: Genomic sequencing (DNA, RNA), EHR (diagnoses, treatments, outcomes), imaging, pathology
🕒 Time coverage: Continuously updated, with historical data available
👥 Population covered: Hundreds of thousands of patients across multiple cancer types and diseases
🔄 Longitudinal data: Linked clinical and genomic data for treatment response tracking
📈 Pathologies: Strong focus on oncology, neurodegenerative diseases, and rare genetic disorders

-

✅ Strengths & Best Use Cases

🌍 Comprehensive genomic & clinical data – Integrates sequencing with patient health records
💊 Biomarker-driven research – Supports targeted therapy development and precision oncology studies
📈 Real-world treatment response tracking – Enables analysis of drug effectiveness based on molecular profiles
🏥 Multimodal dataset – Combines genomics, imaging, and structured/unstructured clinical data
🚀 Ideal for RWE, precision medicine, and drug development research

-

⚠️ Limitations & Considerations

📉 Primarily oncology-focused – Limited representation of non-cancer conditions
🏥 Dependent on data partnerships – Access to full treatment history may require additional linkage
🔄 Complex data integration – Requires expertise in combining genomic and clinical datasets

📚 How to Access & Learn More

🔗 Access: Available through Tempus research collaborations and data solutions
🎓 Publications: Link to relevant studies
📄 More info: Tempus Real-World Data Solutions